Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Updated Food Recall Warning (Allergen) - Fresh lychees recalled due to undeclared sulphites


OTTAWA, Sept. 6, 2018 /CNW/ - The food recall warning issued on August 31, 2018, has been updated to include additional distribution information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation.

Monco Produce Inc. is recalling fresh lychees from the marketplace because they contain sulphites which are not declared on the label. People with a sensitivity to sulphites should not consume the recalled product described below.

The affected product was sold in bulk or may have been packed by retail stores in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, and possibly other provinces or territories. Consumers who are unsure if they have purchased affected product should check with their retail store.

Recalled product

 

Brand

Product

Size

UPC

Codes

None

Fresh lychees

Variable

None

Sold from August 7 up to and including August 31, 2018

 

What you should do

Check to see if you have recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.

If you have a sensitivity to sulphites, do not consume the recalled product as it may cause a serious or life-threatening reaction.

Background

This recall was triggered by CFIA test results. The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing recalled product from the marketplace.

Reactions

There have been no reported reactions associated with the consumption of this product.

More information

 

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: